Literature DB >> 12359438

A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.

Michael H Newberg1, Marcelo J Kuroda, William A Charini, Ayako Miura, Carol I Lord, Jörn E Schmitz, Darci A Gorgone, Michelle A Lifton, Kristine Kuus-Reichel, Norman L Letvin.   

Abstract

The precise measurement of epitope-specific cytotoxic T lymphocyte (CTL) responses in simian immunodeficiency virus (SIV)- and simian-human immunodeficiency virus (SHIV)-infected or vaccinated rhesus monkeys has been important in the evaluation of potential HIV vaccine strategies. This quantitation of CTL has been limited to date by the identification of only one dominant SIV/SHIV epitope in these monkeys. We have recently defined a Nef CTL epitope p199RY (YTSGPGIRY) that is recognized by CD8(+) T lymphocytes from all SIV/SHIV-infected Mamu-A*02(+) rhesus monkeys that have been evaluated. We now measure the frequency of p199RY-specific CD8(+) T lymphocytes in the peripheral blood of these monkeys with quantitative precision, using MHC class I/peptide tetramer staining and peptide-stimulated interferon-gamma Elispot assays. These epitope-specific CD8(+) T lymphocytes are present at a very high frequency and represent a significant proportion of the entire SIV- or SHIV-specific CD8(+) T lymphocyte population in SIV/SHIV-infected Mamu-A*02(+) rhesus monkeys. Knowledge of this dominant CTL epitope should prove valuable in the evaluation of HIV vaccine strategies using this animal model.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12359438     DOI: 10.1006/viro.2002.1598

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge.

Authors:  Margherita Rosati; Agneta von Gegerfelt; Patricia Roth; Candido Alicea; Antonio Valentin; Marjorie Robert-Guroff; David Venzon; David C Montefiori; Phil Markham; Barbara K Felber; George N Pavlakis
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses.

Authors:  Edwin R Manuel; William A Charini; Pritha Sen; Fred W Peyerl; Marcelo J Kuroda; Jörn E Schmitz; Patrick Autissier; Dennis A Sheeter; Bruce E Torbett; Norman L Letvin
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

3.  Vaccine-elicited memory cytotoxic T lymphocytes contribute to Mamu-A*01-associated control of simian/human immunodeficiency virus 89.6P replication in rhesus monkeys.

Authors:  Michael S Seaman; Sampa Santra; Michael H Newberg; Valerie Philippon; Kelledy Manson; Ling Xu; Rebecca S Gelman; Dennis Panicali; John R Mascola; Gary J Nabel; Norman L Letvin
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Unparalleled complexity of the MHC class I region in rhesus macaques.

Authors:  Nel Otting; Corrine M C Heijmans; Riet C Noort; Natasja G de Groot; Gaby G M Doxiadis; Jon J van Rood; David I Watkins; Ronald E Bontrop
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-21       Impact factor: 11.205

5.  Microsatellite typing of the rhesus macaque MHC region.

Authors:  M Cecilia T Penedo; Ronald E Bontrop; Corrine M C Heijmans; Nel Otting; Riet Noort; Annemiek J M Rouweler; Nanine de Groot; Natasja G de Groot; Thea Ward; Gaby G M Doxiadis
Journal:  Immunogenetics       Date:  2005-04-05       Impact factor: 2.846

Review 6.  DNA vaccines against human immunodeficiency virus type 1 in the past decade.

Authors:  Malavika Giri; Kenneth E Ugen; David B Weiner
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

7.  Maintenance or emergence of chronic phase secondary cytotoxic T lymphocyte responses after loss of acute phase immunodominant responses does not protect SIV-infected rhesus macaques from disease progression.

Authors:  M Shannon Keckler; Vida L Hodara; Laura M Parodi; Luis D Giavedoni
Journal:  J Biomed Biotechnol       Date:  2010-05-25

8.  Nef modulates the immunogenicity of Gag encoded in a non-infectious HIV DNA vaccine.

Authors:  Geraldine Arrode; Ramakrishna Hegde; Yuhuai Jin; Dinesh Kumar Singh; Opendra Narayan; Yahia Chebloune
Journal:  Vaccine       Date:  2008-06-17       Impact factor: 3.641

9.  Clonal focusing of epitope-specific CD8+ T lymphocytes in rhesus monkeys following vaccination and simian-human immunodeficiency virus challenge.

Authors:  Pritha Sen; William A Charini; Ramu A Subbramanian; Edwin R Manuel; Marcelo J Kuroda; Patrick A Autissier; Norman L Letvin
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

10.  Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus.

Authors:  Edwin R Manuel; Wendy W Yeh; Michael S Seaman; Kathryn Furr; Michelle A Lifton; Sandrine L Hulot; Patrick Autissier; Norman L Letvin
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.